nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.0925	0.157	CrCrCtD
Trimipramine—Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.0807	0.137	CrCrCtD
Trimipramine—Dimetacrine—Tamoxifen—pancreatic cancer	0.0719	0.122	CrCrCtD
Trimipramine—Methadone—Tamoxifen—pancreatic cancer	0.0675	0.115	CrCrCtD
Trimipramine—Clofedanol—Tamoxifen—pancreatic cancer	0.0584	0.0992	CrCrCtD
Trimipramine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0565	0.0961	CrCrCtD
Trimipramine—Benzphetamine—Tamoxifen—pancreatic cancer	0.0565	0.0961	CrCrCtD
Trimipramine—Promazine—Tamoxifen—pancreatic cancer	0.0539	0.0917	CrCrCtD
Trimipramine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0502	0.0853	CrCrCtD
Trimipramine—CYP2C19—Tamoxifen—pancreatic cancer	0.0212	0.0977	CbGbCtD
Trimipramine—CYP2C9—Tamoxifen—pancreatic cancer	0.0176	0.0812	CbGbCtD
Trimipramine—ABCB1—Tamoxifen—pancreatic cancer	0.0171	0.0788	CbGbCtD
Trimipramine—CYP2D6—Tamoxifen—pancreatic cancer	0.0161	0.0743	CbGbCtD
Trimipramine—ABCB1—Gemcitabine—pancreatic cancer	0.0147	0.0679	CbGbCtD
Trimipramine—ABCB1—Erlotinib—pancreatic cancer	0.0145	0.067	CbGbCtD
Trimipramine—CYP2D6—Erlotinib—pancreatic cancer	0.0137	0.0632	CbGbCtD
Trimipramine—ABCB1—Irinotecan—pancreatic cancer	0.0131	0.0605	CbGbCtD
Trimipramine—CYP2C9—Fluorouracil—pancreatic cancer	0.013	0.0599	CbGbCtD
Trimipramine—HTR3A—enteric nervous system—pancreatic cancer	0.0104	0.528	CbGeAlD
Trimipramine—CYP3A4—Tamoxifen—pancreatic cancer	0.0102	0.0472	CbGbCtD
Trimipramine—ABCB1—Docetaxel—pancreatic cancer	0.00962	0.0444	CbGbCtD
Trimipramine—ABCB1—Sunitinib—pancreatic cancer	0.00957	0.0442	CbGbCtD
Trimipramine—CYP3A4—Erlotinib—pancreatic cancer	0.0087	0.0402	CbGbCtD
Trimipramine—CYP3A4—Irinotecan—pancreatic cancer	0.00786	0.0363	CbGbCtD
Trimipramine—ABCB1—Doxorubicin—pancreatic cancer	0.00717	0.0331	CbGbCtD
Trimipramine—CYP2D6—Doxorubicin—pancreatic cancer	0.00675	0.0312	CbGbCtD
Trimipramine—CYP3A4—Docetaxel—pancreatic cancer	0.00576	0.0266	CbGbCtD
Trimipramine—CYP3A4—Sunitinib—pancreatic cancer	0.00573	0.0265	CbGbCtD
Trimipramine—CYP3A4—Doxorubicin—pancreatic cancer	0.00429	0.0198	CbGbCtD
Trimipramine—HTR2A—enteric nervous system—pancreatic cancer	0.0042	0.213	CbGeAlD
Trimipramine—HTR3A—islet of Langerhans—pancreatic cancer	0.000996	0.0505	CbGeAlD
Trimipramine—HTR3A—digestive system—pancreatic cancer	0.000598	0.0303	CbGeAlD
Trimipramine—ADRA2A—islet of Langerhans—pancreatic cancer	0.000472	0.024	CbGeAlD
Trimipramine—SLC6A4—digestive system—pancreatic cancer	0.000456	0.0231	CbGeAlD
Trimipramine—CYP2C19—digestive system—pancreatic cancer	0.000378	0.0192	CbGeAlD
Trimipramine—ADRA2A—pancreas—pancreatic cancer	0.000332	0.0168	CbGeAlD
Trimipramine—CYP2C9—digestive system—pancreatic cancer	0.000293	0.0148	CbGeAlD
Trimipramine—HRH1—digestive system—pancreatic cancer	0.000289	0.0146	CbGeAlD
Trimipramine—ABCB1—islet of Langerhans—pancreatic cancer	0.000263	0.0133	CbGeAlD
Trimipramine—Vascular purpura—Epirubicin—pancreatic cancer	0.000258	0.00282	CcSEcCtD
Trimipramine—Hypertension—Irinotecan—pancreatic cancer	0.000257	0.00281	CcSEcCtD
Trimipramine—Jaundice—Docetaxel—pancreatic cancer	0.000257	0.00281	CcSEcCtD
Trimipramine—Stomatitis—Docetaxel—pancreatic cancer	0.000257	0.00281	CcSEcCtD
Trimipramine—Decreased appetite—Sunitinib—pancreatic cancer	0.000257	0.00281	CcSEcCtD
Trimipramine—Fatigue—Sunitinib—pancreatic cancer	0.000254	0.00278	CcSEcCtD
Trimipramine—Constipation—Sunitinib—pancreatic cancer	0.000252	0.00276	CcSEcCtD
Trimipramine—Discomfort—Irinotecan—pancreatic cancer	0.000251	0.00274	CcSEcCtD
Trimipramine—Hypertension—Gemcitabine—pancreatic cancer	0.000251	0.00274	CcSEcCtD
Trimipramine—Asthenia—Tamoxifen—pancreatic cancer	0.000247	0.0027	CcSEcCtD
Trimipramine—Convulsion—Fluorouracil—pancreatic cancer	0.000247	0.0027	CcSEcCtD
Trimipramine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000246	0.00269	CcSEcCtD
Trimipramine—Confusional state—Irinotecan—pancreatic cancer	0.000245	0.00268	CcSEcCtD
Trimipramine—Asthenia—Erlotinib—pancreatic cancer	0.000245	0.00268	CcSEcCtD
Trimipramine—Discomfort—Gemcitabine—pancreatic cancer	0.000244	0.00267	CcSEcCtD
Trimipramine—Pruritus—Tamoxifen—pancreatic cancer	0.000244	0.00267	CcSEcCtD
Trimipramine—Oedema—Irinotecan—pancreatic cancer	0.000243	0.00266	CcSEcCtD
Trimipramine—Pruritus—Erlotinib—pancreatic cancer	0.000241	0.00264	CcSEcCtD
Trimipramine—HTR2A—digestive system—pancreatic cancer	0.000241	0.0122	CbGeAlD
Trimipramine—Discomfort—Fluorouracil—pancreatic cancer	0.00024	0.00263	CcSEcCtD
Trimipramine—Purpura—Epirubicin—pancreatic cancer	0.000239	0.00262	CcSEcCtD
Trimipramine—Vascular purpura—Doxorubicin—pancreatic cancer	0.000239	0.00261	CcSEcCtD
Trimipramine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000238	0.0026	CcSEcCtD
Trimipramine—Oedema—Gemcitabine—pancreatic cancer	0.000237	0.00259	CcSEcCtD
Trimipramine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000236	0.00258	CcSEcCtD
Trimipramine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000235	0.00257	CcSEcCtD
Trimipramine—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000235	0.00257	CcSEcCtD
Trimipramine—Confusional state—Fluorouracil—pancreatic cancer	0.000235	0.00257	CcSEcCtD
Trimipramine—Abdominal pain—Sunitinib—pancreatic cancer	0.000233	0.00255	CcSEcCtD
Trimipramine—Body temperature increased—Sunitinib—pancreatic cancer	0.000233	0.00255	CcSEcCtD
Trimipramine—Diarrhoea—Erlotinib—pancreatic cancer	0.000233	0.00255	CcSEcCtD
Trimipramine—Oedema—Fluorouracil—pancreatic cancer	0.000233	0.00255	CcSEcCtD
Trimipramine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000232	0.00254	CcSEcCtD
Trimipramine—Anorexia—Irinotecan—pancreatic cancer	0.000232	0.00254	CcSEcCtD
Trimipramine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000228	0.00249	CcSEcCtD
Trimipramine—Dizziness—Tamoxifen—pancreatic cancer	0.000228	0.00249	CcSEcCtD
Trimipramine—Tachycardia—Fluorouracil—pancreatic cancer	0.000227	0.00249	CcSEcCtD
Trimipramine—Hypotension—Irinotecan—pancreatic cancer	0.000227	0.00249	CcSEcCtD
Trimipramine—Anorexia—Gemcitabine—pancreatic cancer	0.000226	0.00247	CcSEcCtD
Trimipramine—Dizziness—Erlotinib—pancreatic cancer	0.000225	0.00247	CcSEcCtD
Trimipramine—CYP3A4—digestive system—pancreatic cancer	0.000223	0.0113	CbGeAlD
Trimipramine—Anorexia—Fluorouracil—pancreatic cancer	0.000222	0.00243	CcSEcCtD
Trimipramine—Purpura—Doxorubicin—pancreatic cancer	0.000221	0.00242	CcSEcCtD
Trimipramine—Hypotension—Gemcitabine—pancreatic cancer	0.000221	0.00242	CcSEcCtD
Trimipramine—Insomnia—Irinotecan—pancreatic cancer	0.00022	0.00241	CcSEcCtD
Trimipramine—CYP2D6—digestive system—pancreatic cancer	0.00022	0.0111	CbGeAlD
Trimipramine—Flushing—Docetaxel—pancreatic cancer	0.00022	0.0024	CcSEcCtD
Trimipramine—Vomiting—Tamoxifen—pancreatic cancer	0.000219	0.0024	CcSEcCtD
Trimipramine—Paraesthesia—Irinotecan—pancreatic cancer	0.000218	0.00239	CcSEcCtD
Trimipramine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000218	0.00238	CcSEcCtD
Trimipramine—Hypotension—Fluorouracil—pancreatic cancer	0.000218	0.00238	CcSEcCtD
Trimipramine—Rash—Tamoxifen—pancreatic cancer	0.000217	0.00238	CcSEcCtD
Trimipramine—Dermatitis—Tamoxifen—pancreatic cancer	0.000217	0.00237	CcSEcCtD
Trimipramine—Ataxia—Epirubicin—pancreatic cancer	0.000217	0.00237	CcSEcCtD
Trimipramine—Vomiting—Erlotinib—pancreatic cancer	0.000217	0.00237	CcSEcCtD
Trimipramine—Somnolence—Irinotecan—pancreatic cancer	0.000216	0.00236	CcSEcCtD
Trimipramine—Headache—Tamoxifen—pancreatic cancer	0.000216	0.00236	CcSEcCtD
Trimipramine—Rash—Erlotinib—pancreatic cancer	0.000215	0.00235	CcSEcCtD
Trimipramine—Dermatitis—Erlotinib—pancreatic cancer	0.000215	0.00235	CcSEcCtD
Trimipramine—Insomnia—Gemcitabine—pancreatic cancer	0.000214	0.00234	CcSEcCtD
Trimipramine—Dyspepsia—Irinotecan—pancreatic cancer	0.000214	0.00234	CcSEcCtD
Trimipramine—Headache—Erlotinib—pancreatic cancer	0.000214	0.00234	CcSEcCtD
Trimipramine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000213	0.00233	CcSEcCtD
Trimipramine—Asthenia—Sunitinib—pancreatic cancer	0.000212	0.00232	CcSEcCtD
Trimipramine—Decreased appetite—Irinotecan—pancreatic cancer	0.000211	0.00231	CcSEcCtD
Trimipramine—Arrhythmia—Docetaxel—pancreatic cancer	0.000211	0.00231	CcSEcCtD
Trimipramine—Insomnia—Fluorouracil—pancreatic cancer	0.000211	0.0023	CcSEcCtD
Trimipramine—Somnolence—Gemcitabine—pancreatic cancer	0.000211	0.0023	CcSEcCtD
Trimipramine—Fatigue—Irinotecan—pancreatic cancer	0.00021	0.00229	CcSEcCtD
Trimipramine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000209	0.00229	CcSEcCtD
Trimipramine—Alopecia—Docetaxel—pancreatic cancer	0.000209	0.00229	CcSEcCtD
Trimipramine—Pruritus—Sunitinib—pancreatic cancer	0.000209	0.00228	CcSEcCtD
Trimipramine—Constipation—Irinotecan—pancreatic cancer	0.000208	0.00227	CcSEcCtD
Trimipramine—Somnolence—Fluorouracil—pancreatic cancer	0.000207	0.00226	CcSEcCtD
Trimipramine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000206	0.00225	CcSEcCtD
Trimipramine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000205	0.00224	CcSEcCtD
Trimipramine—Nausea—Tamoxifen—pancreatic cancer	0.000205	0.00224	CcSEcCtD
Trimipramine—Fatigue—Gemcitabine—pancreatic cancer	0.000204	0.00223	CcSEcCtD
Trimipramine—Constipation—Gemcitabine—pancreatic cancer	0.000203	0.00222	CcSEcCtD
Trimipramine—Nausea—Erlotinib—pancreatic cancer	0.000203	0.00222	CcSEcCtD
Trimipramine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000202	0.00221	CcSEcCtD
Trimipramine—Diarrhoea—Sunitinib—pancreatic cancer	0.000202	0.00221	CcSEcCtD
Trimipramine—Dysgeusia—Docetaxel—pancreatic cancer	0.000202	0.00221	CcSEcCtD
Trimipramine—Ataxia—Doxorubicin—pancreatic cancer	0.000201	0.0022	CcSEcCtD
Trimipramine—Feeling abnormal—Irinotecan—pancreatic cancer	0.0002	0.00219	CcSEcCtD
Trimipramine—Eosinophilia—Epirubicin—pancreatic cancer	0.000197	0.00216	CcSEcCtD
Trimipramine—Dizziness—Sunitinib—pancreatic cancer	0.000195	0.00214	CcSEcCtD
Trimipramine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000195	0.00213	CcSEcCtD
Trimipramine—Abdominal pain—Irinotecan—pancreatic cancer	0.000192	0.0021	CcSEcCtD
Trimipramine—Body temperature increased—Irinotecan—pancreatic cancer	0.000192	0.0021	CcSEcCtD
Trimipramine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000192	0.0021	CcSEcCtD
Trimipramine—Pancytopenia—Epirubicin—pancreatic cancer	0.000189	0.00207	CcSEcCtD
Trimipramine—Vomiting—Sunitinib—pancreatic cancer	0.000188	0.00205	CcSEcCtD
Trimipramine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000187	0.00205	CcSEcCtD
Trimipramine—Rash—Sunitinib—pancreatic cancer	0.000186	0.00204	CcSEcCtD
Trimipramine—Dermatitis—Sunitinib—pancreatic cancer	0.000186	0.00203	CcSEcCtD
Trimipramine—ABCB1—pancreas—pancreatic cancer	0.000185	0.00938	CbGeAlD
Trimipramine—Urticaria—Fluorouracil—pancreatic cancer	0.000185	0.00202	CcSEcCtD
Trimipramine—Headache—Sunitinib—pancreatic cancer	0.000185	0.00202	CcSEcCtD
Trimipramine—Pollakiuria—Epirubicin—pancreatic cancer	0.000184	0.00201	CcSEcCtD
Trimipramine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000184	0.00201	CcSEcCtD
Trimipramine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000183	0.002	CcSEcCtD
Trimipramine—Palpitations—Docetaxel—pancreatic cancer	0.000182	0.00199	CcSEcCtD
Trimipramine—Weight increased—Epirubicin—pancreatic cancer	0.000181	0.00198	CcSEcCtD
Trimipramine—Convulsion—Docetaxel—pancreatic cancer	0.000178	0.00195	CcSEcCtD
Trimipramine—Hypertension—Docetaxel—pancreatic cancer	0.000178	0.00194	CcSEcCtD
Trimipramine—Drowsiness—Epirubicin—pancreatic cancer	0.000178	0.00194	CcSEcCtD
Trimipramine—Nausea—Sunitinib—pancreatic cancer	0.000175	0.00192	CcSEcCtD
Trimipramine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000175	0.00192	CcSEcCtD
Trimipramine—Asthenia—Irinotecan—pancreatic cancer	0.000174	0.00191	CcSEcCtD
Trimipramine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000174	0.00191	CcSEcCtD
Trimipramine—Jaundice—Epirubicin—pancreatic cancer	0.000173	0.0019	CcSEcCtD
Trimipramine—Stomatitis—Epirubicin—pancreatic cancer	0.000173	0.0019	CcSEcCtD
Trimipramine—Dry mouth—Docetaxel—pancreatic cancer	0.000171	0.00188	CcSEcCtD
Trimipramine—Pollakiuria—Doxorubicin—pancreatic cancer	0.00017	0.00186	CcSEcCtD
Trimipramine—Asthenia—Gemcitabine—pancreatic cancer	0.00017	0.00186	CcSEcCtD
Trimipramine—Confusional state—Docetaxel—pancreatic cancer	0.000169	0.00185	CcSEcCtD
Trimipramine—Oedema—Docetaxel—pancreatic cancer	0.000168	0.00184	CcSEcCtD
Trimipramine—Weight increased—Doxorubicin—pancreatic cancer	0.000168	0.00184	CcSEcCtD
Trimipramine—Pruritus—Gemcitabine—pancreatic cancer	0.000168	0.00183	CcSEcCtD
Trimipramine—Diarrhoea—Irinotecan—pancreatic cancer	0.000166	0.00182	CcSEcCtD
Trimipramine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000166	0.00181	CcSEcCtD
Trimipramine—Pruritus—Fluorouracil—pancreatic cancer	0.000165	0.0018	CcSEcCtD
Trimipramine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000165	0.0018	CcSEcCtD
Trimipramine—Drowsiness—Doxorubicin—pancreatic cancer	0.000164	0.0018	CcSEcCtD
Trimipramine—Tachycardia—Docetaxel—pancreatic cancer	0.000164	0.00179	CcSEcCtD
Trimipramine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000162	0.00177	CcSEcCtD
Trimipramine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000161	0.00176	CcSEcCtD
Trimipramine—Dizziness—Irinotecan—pancreatic cancer	0.000161	0.00176	CcSEcCtD
Trimipramine—Stomatitis—Doxorubicin—pancreatic cancer	0.00016	0.00175	CcSEcCtD
Trimipramine—Jaundice—Doxorubicin—pancreatic cancer	0.00016	0.00175	CcSEcCtD
Trimipramine—Anorexia—Docetaxel—pancreatic cancer	0.00016	0.00175	CcSEcCtD
Trimipramine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000159	0.00174	CcSEcCtD
Trimipramine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000159	0.00174	CcSEcCtD
Trimipramine—ABCB1—digestive system—pancreatic cancer	0.000158	0.00801	CbGeAlD
Trimipramine—Hypotension—Docetaxel—pancreatic cancer	0.000157	0.00172	CcSEcCtD
Trimipramine—Vomiting—Irinotecan—pancreatic cancer	0.000155	0.00169	CcSEcCtD
Trimipramine—Dizziness—Fluorouracil—pancreatic cancer	0.000154	0.00168	CcSEcCtD
Trimipramine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000153	0.00168	CcSEcCtD
Trimipramine—Rash—Irinotecan—pancreatic cancer	0.000153	0.00168	CcSEcCtD
Trimipramine—Dermatitis—Irinotecan—pancreatic cancer	0.000153	0.00168	CcSEcCtD
Trimipramine—Headache—Irinotecan—pancreatic cancer	0.000152	0.00167	CcSEcCtD
Trimipramine—Insomnia—Docetaxel—pancreatic cancer	0.000152	0.00166	CcSEcCtD
Trimipramine—Paraesthesia—Docetaxel—pancreatic cancer	0.000151	0.00165	CcSEcCtD
Trimipramine—Vomiting—Gemcitabine—pancreatic cancer	0.000151	0.00165	CcSEcCtD
Trimipramine—Somnolence—Docetaxel—pancreatic cancer	0.000149	0.00163	CcSEcCtD
Trimipramine—Rash—Gemcitabine—pancreatic cancer	0.000149	0.00163	CcSEcCtD
Trimipramine—Dermatitis—Gemcitabine—pancreatic cancer	0.000149	0.00163	CcSEcCtD
Trimipramine—Tinnitus—Epirubicin—pancreatic cancer	0.000149	0.00163	CcSEcCtD
Trimipramine—Headache—Gemcitabine—pancreatic cancer	0.000148	0.00162	CcSEcCtD
Trimipramine—Flushing—Epirubicin—pancreatic cancer	0.000148	0.00162	CcSEcCtD
Trimipramine—Vomiting—Fluorouracil—pancreatic cancer	0.000148	0.00162	CcSEcCtD
Trimipramine—Dyspepsia—Docetaxel—pancreatic cancer	0.000148	0.00162	CcSEcCtD
Trimipramine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000147	0.00161	CcSEcCtD
Trimipramine—Rash—Fluorouracil—pancreatic cancer	0.000147	0.00161	CcSEcCtD
Trimipramine—Dermatitis—Fluorouracil—pancreatic cancer	0.000147	0.0016	CcSEcCtD
Trimipramine—Decreased appetite—Docetaxel—pancreatic cancer	0.000146	0.0016	CcSEcCtD
Trimipramine—Headache—Fluorouracil—pancreatic cancer	0.000146	0.0016	CcSEcCtD
Trimipramine—Fatigue—Docetaxel—pancreatic cancer	0.000145	0.00159	CcSEcCtD
Trimipramine—Nausea—Irinotecan—pancreatic cancer	0.000144	0.00158	CcSEcCtD
Trimipramine—Constipation—Docetaxel—pancreatic cancer	0.000144	0.00157	CcSEcCtD
Trimipramine—Arrhythmia—Epirubicin—pancreatic cancer	0.000143	0.00156	CcSEcCtD
Trimipramine—Alopecia—Epirubicin—pancreatic cancer	0.000141	0.00154	CcSEcCtD
Trimipramine—Nausea—Gemcitabine—pancreatic cancer	0.000141	0.00154	CcSEcCtD
Trimipramine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000138	0.00152	CcSEcCtD
Trimipramine—Nausea—Fluorouracil—pancreatic cancer	0.000138	0.00151	CcSEcCtD
Trimipramine—Tinnitus—Doxorubicin—pancreatic cancer	0.000138	0.00151	CcSEcCtD
Trimipramine—Flushing—Doxorubicin—pancreatic cancer	0.000137	0.0015	CcSEcCtD
Trimipramine—Dysgeusia—Epirubicin—pancreatic cancer	0.000136	0.00149	CcSEcCtD
Trimipramine—Abdominal pain—Docetaxel—pancreatic cancer	0.000133	0.00145	CcSEcCtD
Trimipramine—Body temperature increased—Docetaxel—pancreatic cancer	0.000133	0.00145	CcSEcCtD
Trimipramine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000132	0.00144	CcSEcCtD
Trimipramine—Vision blurred—Epirubicin—pancreatic cancer	0.000131	0.00143	CcSEcCtD
Trimipramine—Alopecia—Doxorubicin—pancreatic cancer	0.00013	0.00143	CcSEcCtD
Trimipramine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000129	0.00141	CcSEcCtD
Trimipramine—Agitation—Epirubicin—pancreatic cancer	0.000128	0.0014	CcSEcCtD
Trimipramine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000126	0.00138	CcSEcCtD
Trimipramine—Malaise—Epirubicin—pancreatic cancer	0.000125	0.00137	CcSEcCtD
Trimipramine—Palpitations—Epirubicin—pancreatic cancer	0.000123	0.00134	CcSEcCtD
Trimipramine—Vision blurred—Doxorubicin—pancreatic cancer	0.000121	0.00133	CcSEcCtD
Trimipramine—Asthenia—Docetaxel—pancreatic cancer	0.000121	0.00132	CcSEcCtD
Trimipramine—Convulsion—Epirubicin—pancreatic cancer	0.00012	0.00132	CcSEcCtD
Trimipramine—Hypertension—Epirubicin—pancreatic cancer	0.00012	0.00131	CcSEcCtD
Trimipramine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000119	0.0013	CcSEcCtD
Trimipramine—Pruritus—Docetaxel—pancreatic cancer	0.000119	0.0013	CcSEcCtD
Trimipramine—Agitation—Doxorubicin—pancreatic cancer	0.000118	0.00129	CcSEcCtD
Trimipramine—Anxiety—Epirubicin—pancreatic cancer	0.000118	0.00129	CcSEcCtD
Trimipramine—Discomfort—Epirubicin—pancreatic cancer	0.000117	0.00128	CcSEcCtD
Trimipramine—Malaise—Doxorubicin—pancreatic cancer	0.000116	0.00127	CcSEcCtD
Trimipramine—Dry mouth—Epirubicin—pancreatic cancer	0.000116	0.00127	CcSEcCtD
Trimipramine—Diarrhoea—Docetaxel—pancreatic cancer	0.000115	0.00126	CcSEcCtD
Trimipramine—Confusional state—Epirubicin—pancreatic cancer	0.000114	0.00125	CcSEcCtD
Trimipramine—Palpitations—Doxorubicin—pancreatic cancer	0.000114	0.00124	CcSEcCtD
Trimipramine—Oedema—Epirubicin—pancreatic cancer	0.000113	0.00124	CcSEcCtD
Trimipramine—Convulsion—Doxorubicin—pancreatic cancer	0.000111	0.00122	CcSEcCtD
Trimipramine—Dizziness—Docetaxel—pancreatic cancer	0.000111	0.00122	CcSEcCtD
Trimipramine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Trimipramine—Hypertension—Doxorubicin—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Trimipramine—Tachycardia—Epirubicin—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Trimipramine—Anxiety—Doxorubicin—pancreatic cancer	0.000109	0.00119	CcSEcCtD
Trimipramine—Discomfort—Doxorubicin—pancreatic cancer	0.000108	0.00118	CcSEcCtD
Trimipramine—Anorexia—Epirubicin—pancreatic cancer	0.000108	0.00118	CcSEcCtD
Trimipramine—Dry mouth—Doxorubicin—pancreatic cancer	0.000107	0.00117	CcSEcCtD
Trimipramine—Vomiting—Docetaxel—pancreatic cancer	0.000107	0.00117	CcSEcCtD
Trimipramine—Rash—Docetaxel—pancreatic cancer	0.000106	0.00116	CcSEcCtD
Trimipramine—Hypotension—Epirubicin—pancreatic cancer	0.000106	0.00116	CcSEcCtD
Trimipramine—Dermatitis—Docetaxel—pancreatic cancer	0.000106	0.00116	CcSEcCtD
Trimipramine—Confusional state—Doxorubicin—pancreatic cancer	0.000106	0.00116	CcSEcCtD
Trimipramine—Headache—Docetaxel—pancreatic cancer	0.000105	0.00115	CcSEcCtD
Trimipramine—Oedema—Doxorubicin—pancreatic cancer	0.000105	0.00115	CcSEcCtD
Trimipramine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000103	0.00112	CcSEcCtD
Trimipramine—Insomnia—Epirubicin—pancreatic cancer	0.000103	0.00112	CcSEcCtD
Trimipramine—Tachycardia—Doxorubicin—pancreatic cancer	0.000102	0.00112	CcSEcCtD
Trimipramine—Paraesthesia—Epirubicin—pancreatic cancer	0.000102	0.00111	CcSEcCtD
Trimipramine—Somnolence—Epirubicin—pancreatic cancer	0.000101	0.0011	CcSEcCtD
Trimipramine—Anorexia—Doxorubicin—pancreatic cancer	0.0001	0.00109	CcSEcCtD
Trimipramine—Nausea—Docetaxel—pancreatic cancer	9.98e-05	0.00109	CcSEcCtD
Trimipramine—Dyspepsia—Epirubicin—pancreatic cancer	9.98e-05	0.00109	CcSEcCtD
Trimipramine—Decreased appetite—Epirubicin—pancreatic cancer	9.85e-05	0.00108	CcSEcCtD
Trimipramine—Hypotension—Doxorubicin—pancreatic cancer	9.8e-05	0.00107	CcSEcCtD
Trimipramine—Fatigue—Epirubicin—pancreatic cancer	9.77e-05	0.00107	CcSEcCtD
Trimipramine—Constipation—Epirubicin—pancreatic cancer	9.69e-05	0.00106	CcSEcCtD
Trimipramine—Insomnia—Doxorubicin—pancreatic cancer	9.49e-05	0.00104	CcSEcCtD
Trimipramine—Paraesthesia—Doxorubicin—pancreatic cancer	9.42e-05	0.00103	CcSEcCtD
Trimipramine—Feeling abnormal—Epirubicin—pancreatic cancer	9.34e-05	0.00102	CcSEcCtD
Trimipramine—Somnolence—Doxorubicin—pancreatic cancer	9.32e-05	0.00102	CcSEcCtD
Trimipramine—Dyspepsia—Doxorubicin—pancreatic cancer	9.23e-05	0.00101	CcSEcCtD
Trimipramine—Decreased appetite—Doxorubicin—pancreatic cancer	9.12e-05	0.000997	CcSEcCtD
Trimipramine—Fatigue—Doxorubicin—pancreatic cancer	9.04e-05	0.000989	CcSEcCtD
Trimipramine—Urticaria—Epirubicin—pancreatic cancer	9.01e-05	0.000985	CcSEcCtD
Trimipramine—Constipation—Doxorubicin—pancreatic cancer	8.97e-05	0.000981	CcSEcCtD
Trimipramine—Body temperature increased—Epirubicin—pancreatic cancer	8.96e-05	0.00098	CcSEcCtD
Trimipramine—Abdominal pain—Epirubicin—pancreatic cancer	8.96e-05	0.00098	CcSEcCtD
Trimipramine—Feeling abnormal—Doxorubicin—pancreatic cancer	8.64e-05	0.000946	CcSEcCtD
Trimipramine—Urticaria—Doxorubicin—pancreatic cancer	8.33e-05	0.000912	CcSEcCtD
Trimipramine—Body temperature increased—Doxorubicin—pancreatic cancer	8.29e-05	0.000907	CcSEcCtD
Trimipramine—Abdominal pain—Doxorubicin—pancreatic cancer	8.29e-05	0.000907	CcSEcCtD
Trimipramine—Asthenia—Epirubicin—pancreatic cancer	8.13e-05	0.00089	CcSEcCtD
Trimipramine—Pruritus—Epirubicin—pancreatic cancer	8.02e-05	0.000877	CcSEcCtD
Trimipramine—Diarrhoea—Epirubicin—pancreatic cancer	7.76e-05	0.000848	CcSEcCtD
Trimipramine—Asthenia—Doxorubicin—pancreatic cancer	7.53e-05	0.000823	CcSEcCtD
Trimipramine—Dizziness—Epirubicin—pancreatic cancer	7.5e-05	0.00082	CcSEcCtD
Trimipramine—Pruritus—Doxorubicin—pancreatic cancer	7.42e-05	0.000812	CcSEcCtD
Trimipramine—Vomiting—Epirubicin—pancreatic cancer	7.21e-05	0.000788	CcSEcCtD
Trimipramine—Diarrhoea—Doxorubicin—pancreatic cancer	7.18e-05	0.000785	CcSEcCtD
Trimipramine—Rash—Epirubicin—pancreatic cancer	7.15e-05	0.000782	CcSEcCtD
Trimipramine—Dermatitis—Epirubicin—pancreatic cancer	7.14e-05	0.000781	CcSEcCtD
Trimipramine—Headache—Epirubicin—pancreatic cancer	7.1e-05	0.000777	CcSEcCtD
Trimipramine—Dizziness—Doxorubicin—pancreatic cancer	6.94e-05	0.000759	CcSEcCtD
Trimipramine—Nausea—Epirubicin—pancreatic cancer	6.73e-05	0.000737	CcSEcCtD
Trimipramine—Vomiting—Doxorubicin—pancreatic cancer	6.67e-05	0.00073	CcSEcCtD
Trimipramine—Rash—Doxorubicin—pancreatic cancer	6.61e-05	0.000723	CcSEcCtD
Trimipramine—Dermatitis—Doxorubicin—pancreatic cancer	6.61e-05	0.000723	CcSEcCtD
Trimipramine—Headache—Doxorubicin—pancreatic cancer	6.57e-05	0.000719	CcSEcCtD
Trimipramine—Nausea—Doxorubicin—pancreatic cancer	6.23e-05	0.000682	CcSEcCtD
Trimipramine—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	4.83e-06	5.73e-05	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	4.81e-06	5.71e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	4.79e-06	5.68e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	4.78e-06	5.68e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CD44—pancreatic cancer	4.78e-06	5.68e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	4.76e-06	5.66e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	4.76e-06	5.66e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.75e-06	5.63e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	4.73e-06	5.62e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.72e-06	5.6e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	4.69e-06	5.57e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	4.69e-06	5.56e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	4.66e-06	5.53e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	4.66e-06	5.53e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.65e-06	5.52e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.64e-06	5.51e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	4.64e-06	5.5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.63e-06	5.5e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	4.63e-06	5.5e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	4.62e-06	5.48e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—pancreatic cancer	4.61e-06	5.47e-05	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	4.6e-06	5.46e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	4.6e-06	5.46e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	4.59e-06	5.45e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—GCG—pancreatic cancer	4.58e-06	5.44e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—pancreatic cancer	4.57e-06	5.43e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	4.57e-06	5.43e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	4.56e-06	5.41e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	4.55e-06	5.4e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.54e-06	5.4e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	4.53e-06	5.37e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.52e-06	5.37e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	4.5e-06	5.34e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	4.5e-06	5.34e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	4.5e-06	5.34e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	4.49e-06	5.33e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	4.48e-06	5.31e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	4.44e-06	5.27e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.42e-06	5.24e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	4.4e-06	5.23e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	4.4e-06	5.22e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	4.39e-06	5.21e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	4.39e-06	5.21e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PPARG—pancreatic cancer	4.37e-06	5.18e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	4.37e-06	5.18e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	4.36e-06	5.18e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.33e-06	5.14e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	4.32e-06	5.13e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	4.32e-06	5.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	4.31e-06	5.12e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	4.31e-06	5.12e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—STK11—pancreatic cancer	4.31e-06	5.12e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	4.29e-06	5.1e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	4.29e-06	5.09e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	4.28e-06	5.09e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARG—pancreatic cancer	4.26e-06	5.06e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	4.26e-06	5.05e-05	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	4.24e-06	5.04e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	4.23e-06	5.02e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTEN—pancreatic cancer	4.23e-06	5.02e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.22e-06	5.01e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	4.21e-06	5e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	4.2e-06	4.99e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	4.2e-06	4.99e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	4.18e-06	4.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	4.18e-06	4.96e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	4.17e-06	4.95e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	4.17e-06	4.95e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	4.17e-06	4.95e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.16e-06	4.94e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	4.16e-06	4.94e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	4.15e-06	4.93e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	4.14e-06	4.91e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	4.13e-06	4.9e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.13e-06	4.9e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—pancreatic cancer	4.12e-06	4.89e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	4.09e-06	4.86e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	4.09e-06	4.86e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	4.09e-06	4.85e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	4.06e-06	4.82e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	4.05e-06	4.81e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	4.05e-06	4.81e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	4.04e-06	4.8e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	4.03e-06	4.78e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	4.02e-06	4.78e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	4.02e-06	4.77e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.02e-06	4.77e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	4.01e-06	4.76e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	4e-06	4.75e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	3.99e-06	4.74e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.99e-06	4.73e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.98e-06	4.73e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	3.98e-06	4.72e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.98e-06	4.72e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	3.97e-06	4.72e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	3.97e-06	4.72e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	3.95e-06	4.69e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	3.94e-06	4.68e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	3.94e-06	4.67e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	3.93e-06	4.67e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	3.91e-06	4.64e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	3.91e-06	4.64e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	3.9e-06	4.64e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	3.9e-06	4.63e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	3.89e-06	4.61e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.88e-06	4.61e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	3.88e-06	4.6e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	3.87e-06	4.6e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	3.87e-06	4.59e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	3.86e-06	4.59e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	3.85e-06	4.57e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	3.83e-06	4.55e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	3.83e-06	4.54e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	3.82e-06	4.54e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	3.81e-06	4.52e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	3.8e-06	4.51e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	3.79e-06	4.5e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	3.79e-06	4.5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	3.78e-06	4.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	3.76e-06	4.47e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	3.74e-06	4.44e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	3.73e-06	4.43e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	3.72e-06	4.42e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	3.71e-06	4.41e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	3.71e-06	4.4e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.71e-06	4.4e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	3.66e-06	4.35e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—SRC—pancreatic cancer	3.66e-06	4.35e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.66e-06	4.34e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	3.66e-06	4.34e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	3.64e-06	4.32e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.63e-06	4.31e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.63e-06	4.31e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	3.6e-06	4.28e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—SRC—pancreatic cancer	3.6e-06	4.27e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	3.58e-06	4.25e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	3.57e-06	4.24e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	3.56e-06	4.23e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	3.56e-06	4.22e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	3.55e-06	4.22e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	3.54e-06	4.2e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	3.53e-06	4.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	3.53e-06	4.19e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	3.52e-06	4.18e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	3.51e-06	4.17e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	3.5e-06	4.16e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	3.48e-06	4.13e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	3.48e-06	4.13e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	3.48e-06	4.13e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.47e-06	4.12e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	3.46e-06	4.11e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	3.45e-06	4.1e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	3.45e-06	4.1e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	3.44e-06	4.08e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	3.44e-06	4.08e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.44e-06	4.08e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	3.4e-06	4.04e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	3.4e-06	4.03e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.38e-06	4.02e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.35e-06	3.98e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	3.29e-06	3.91e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	3.29e-06	3.9e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MYC—pancreatic cancer	3.28e-06	3.9e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	3.28e-06	3.89e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	3.27e-06	3.89e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	3.23e-06	3.83e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MYC—pancreatic cancer	3.22e-06	3.83e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	3.22e-06	3.83e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	3.22e-06	3.82e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	3.21e-06	3.81e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	3.19e-06	3.79e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.19e-06	3.79e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	3.18e-06	3.78e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.17e-06	3.77e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	3.16e-06	3.75e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	3.15e-06	3.75e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	3.15e-06	3.74e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	3.15e-06	3.74e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.13e-06	3.72e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	3.09e-06	3.67e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	3.07e-06	3.64e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	3.05e-06	3.63e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	3.04e-06	3.61e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	3.03e-06	3.6e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	3.02e-06	3.59e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—pancreatic cancer	3.01e-06	3.58e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTEN—pancreatic cancer	3e-06	3.56e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	2.98e-06	3.54e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	2.98e-06	3.54e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.98e-06	3.54e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	2.94e-06	3.49e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.94e-06	3.49e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	2.93e-06	3.48e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	2.92e-06	3.47e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	2.87e-06	3.41e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	2.8e-06	3.32e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.79e-06	3.31e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.76e-06	3.27e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.74e-06	3.25e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.74e-06	3.25e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.73e-06	3.24e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.72e-06	3.23e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	2.72e-06	3.22e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.7e-06	3.2e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	2.69e-06	3.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.68e-06	3.19e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.65e-06	3.15e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.65e-06	3.14e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.63e-06	3.12e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	2.6e-06	3.08e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.59e-06	3.08e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	2.58e-06	3.06e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.58e-06	3.06e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.54e-06	3.01e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.53e-06	3e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.49e-06	2.96e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	2.48e-06	2.95e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	2.47e-06	2.93e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—pancreatic cancer	2.44e-06	2.89e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	2.41e-06	2.86e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.39e-06	2.84e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	2.31e-06	2.74e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	2.28e-06	2.7e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.24e-06	2.66e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.24e-06	2.65e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	2.19e-06	2.6e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.11e-06	2.51e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.08e-06	2.48e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.07e-06	2.45e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.06e-06	2.45e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	2.04e-06	2.42e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.94e-06	2.31e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	2.29e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.8e-06	2.14e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.73e-06	2.05e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.69e-06	2e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.59e-06	1.89e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.57e-06	1.87e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	1.51e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.04e-06	1.23e-05	CbGpPWpGaD
